射血分数降低的心力衰竭的管理 - Suppr

Suppr

超能文献

Management of heart failure with reduced ejection fraction.

作者信息

Haydock Paul M, Flett Andrew S

机构信息

Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, UK

出版信息

Heart. 2022 Sep 12;108(19):1571-1579. doi: 10.1136/heartjnl-2020-318811.

DOI:10.1136/heartjnl-2020-318811

PMID:35973784

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9484381/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd45/9484381/792f82fb84cd/heartjnl-2020-318811f01.jpg

相似文献

Management of heart failure with reduced ejection fraction.射血分数降低的心力衰竭的管理

Heart. 2022 Sep 12;108(19):1571-1579. doi: 10.1136/heartjnl-2020-318811.

Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE).心脏再同步治疗对心脏重塑和收缩功能的影响：来自心脏再同步逆转收缩期左心室功能不全重塑（REVERSE）试验的结果

J Am Heart Assoc. 2015 Sep 11;4(9):e002054. doi: 10.1161/JAHA.115.002054.

Opportunistic screening models for high-risk men and women to detect diastolic dysfunction and heart failure with preserved ejection fraction in the community.社区中针对高危男性和女性的机会性筛查模型，以检测舒张功能障碍和射血分数保留型心力衰竭。

Eur J Prev Cardiol. 2019 Apr;26(6):613-623. doi: 10.1177/2047487318816774. Epub 2018 Nov 27.

Heart Failure Across the Range of Mildly Reduced and Preserved Ejection Fraction in the United States.美国射血分数轻度降低和保留范围内的心力衰竭情况

Circ Heart Fail. 2023 May;16(5):e010430. doi: 10.1161/CIRCHEARTFAILURE.123.010430. Epub 2023 Apr 20.

Prevalence of exertional oscillatory ventilation in continuous-flow left ventricular assist device recipients.连续性左心室辅助装置受者中运动性振荡通气的流行情况。

Eur J Prev Cardiol. 2018 Nov;25(17):1838-1842. doi: 10.1177/2047487318801415. Epub 2018 Sep 24.

Contemporary prevalence and correlates of incident heart failure with preserved ejection fraction.当代射血分数保留型心力衰竭的患病率及相关因素。

Am J Med. 2013 May;126(5):393-400. doi: 10.1016/j.amjmed.2012.10.022. Epub 2013 Mar 14.

Tackling the Heterogeneity of Heart Failure with Preserved Ejection Fraction Using Proteomic Profiling.利用蛋白质组学分析应对射血分数保留的心力衰竭的异质性

J Card Fail. 2022 Jun;28(6):947-949. doi: 10.1016/j.cardfail.2022.03.350. Epub 2022 Apr 22.

Updating the Accuracy of Administrative Claims for Identifying Left Ventricular Ejection Fraction Among Patients With Heart Failure.更新行政索赔在识别心力衰竭患者左心室射血分数方面的准确性。

Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e008919. doi: 10.1161/CIRCOUTCOMES.122.008919. Epub 2023 Mar 16.

Implementation Approaches in Heart Failure With Mildly Reduced and Preserved Ejection Fraction.轻度射血分数降低和保留的心力衰竭的实施方法

JACC Heart Fail. 2024 Apr;12(4):628-630. doi: 10.1016/j.jchf.2024.01.013.

Left Ventricular Ejection Fraction in Heart Failure: Crazy, Stupid Love-and Maybe, Redemption.心力衰竭中的左心室射血分数：疯狂、愚蠢的爱——或许还有救赎。

J Am Heart Assoc. 2024 Apr 16;13(8):e034642. doi: 10.1161/JAHA.124.034642. Epub 2024 Apr 9.

引用本文的文献

The Multidisciplinary Approach to GLP-1 RA and SGLT2 Inhibitors in Cardiometabolic Care: A New Era for Patients with Diabetes and Heart Disease.心血管代谢护理中GLP-1受体激动剂和SGLT2抑制剂的多学科应用：糖尿病和心脏病患者的新时代。

J Clin Med. 2025 Jul 8;14(14):4834. doi: 10.3390/jcm14144834.

Impact of probiotics and polyphenols on adults with heart failure: a systematic review and meta-analysis.益生菌和多酚对心力衰竭成人患者的影响：一项系统评价和荟萃分析。

Eur J Med Res. 2025 Apr 21;30(1):313. doi: 10.1186/s40001-025-02538-y.

The Role of SGLT2-Inhibitors Across All Stages of Heart Failure and Mechanisms of Early Clinical Benefit: From Prevention to Advanced Heart Failure.钠-葡萄糖协同转运蛋白2抑制剂在心力衰竭各阶段的作用及早期临床获益机制：从预防到晚期心力衰竭

Biomedicines. 2025 Mar 3;13(3):608. doi: 10.3390/biomedicines13030608.

Heart failure with reduced ejection fraction developed from valvular surgery: Risk factors and therapeutic effects of sacubitril valsartan.瓣膜手术后发生的射血分数降低的心力衰竭：沙库巴曲缬沙坦的危险因素及治疗效果

Int J Cardiol Heart Vasc. 2025 Feb 25;57:101634. doi: 10.1016/j.ijcha.2025.101634. eCollection 2025 Apr.

The association of serum hsa-miR-21-5p expression with the severity and prognosis of heart failure with reduced ejection fraction.血清hsa-miR-21-5p表达与射血分数降低的心力衰竭的严重程度及预后的相关性

BMC Cardiovasc Disord. 2025 Feb 19;25(1):114. doi: 10.1186/s12872-024-04465-y.

Comprehensive Benefits of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure With Reduced Ejection Fraction: A Literature Review.钠-葡萄糖协同转运蛋白2抑制剂在射血分数降低的心力衰竭中的综合益处：文献综述

J Clin Med Res. 2024 Oct;16(10):449-464. doi: 10.14740/jocmr6033. Epub 2024 Oct 11.

Cardiac diastolic dysfunction by cigarette smoking is associated with mitochondrial integrity in the heart.吸烟导致的心脏舒张功能障碍与心脏中线粒体的完整性有关。

FASEB J. 2024 Jul 31;38(14):e23826. doi: 10.1096/fj.202400858R.

Exploring the mechanism of diabetic cardiomyopathy treated with Qigui Qiangxin mixture based on UPLC-Q/TOF-MS, network pharmacology and experimental validation.基于 UPLC-Q/TOF-MS、网络药理学和实验验证探讨芪桂强心合剂治疗糖尿病心肌病的作用机制。

Sci Rep. 2024 May 27;14(1):12119. doi: 10.1038/s41598-024-63088-7.

Exploring the Need and Benefits of Digital Therapeutics (DTx) for the Management of Heart Failure in India.探索数字疗法（DTx）在印度心力衰竭管理中的需求和益处。

Cureus. 2023 Nov 29;15(11):e49628. doi: 10.7759/cureus.49628. eCollection 2023 Nov.

本文引用的文献

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。

Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.

Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.恩格列净治疗射血分数降低且容量超负荷的心力衰竭患者：EMPEROR-Reduced试验

J Am Coll Cardiol. 2021 Mar 23;77(11):1381-1392. doi: 10.1016/j.jacc.2021.01.033.

Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.COPD 患者的β受体阻滞剂治疗：一项系统文献回顾和荟萃分析，采用多种治疗比较。

Respir Res. 2021 Feb 23;22(1):64. doi: 10.1186/s12931-021-01661-8.

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。

N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.

Change in renal function associated with drug treatment in heart failure: national guidance.肾功能变化与心力衰竭药物治疗相关：国家指南。

Heart. 2019 Jun;105(12):904-910. doi: 10.1136/heartjnl-2018-314158.

The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.心力衰竭伴充血时利尿剂的应用——欧洲心脏病学会心力衰竭协会立场声明。

Eur J Heart Fail. 2019 Feb;21(2):137-155. doi: 10.1002/ejhf.1369. Epub 2019 Jan 1.

Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial.恢复性扩张型心肌病患者停止心力衰竭的药物治疗（TRED-HF）：一项开放标签、先导、随机试验。

Lancet. 2019 Jan 5;393(10166):61-73. doi: 10.1016/S0140-6736(18)32484-X. Epub 2018 Nov 11.

Multidisciplinary team approach to heart failure management.心力衰竭管理的多学科团队方法。

Heart. 2018 Aug;104(16):1376-1382. doi: 10.1136/heartjnl-2016-310598. Epub 2017 Nov 23.

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.2017年美国心脏病学会/美国心脏协会/美国心力衰竭学会对2013年美国心脏病学会基金会/美国心脏协会心力衰竭管理指南的重点更新：美国心脏病学会/美国心脏协会临床实践指南工作组及美国心力衰竭学会的报告

J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南：欧洲心脏病学会（ESC）急性和慢性心力衰竭诊断与治疗工作组编写，欧洲心脏病学会心力衰竭协会（HFA）提供特别贡献。

Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验